Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9 studies found for:    TPI | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
2 Recruiting Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
Conditions: Brain Metastases;   Generalized Malignancy, Primary;   Brain Lesions
Interventions: Drug: TPI 287;   Procedure: Fractionated Stereotactic Radiotherapy (FSRT)
3 Not yet recruiting TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone
Condition: Myofascial Pain
Interventions: Drug: Ketorolac;   Drug: Lidocaine;   Drug: Dexamethasone
4 Recruiting Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain
Condition: Abdominal Pain
Interventions: Drug: Bupivacaine 0.25%;   Drug: Triamcinolone
5 Not yet recruiting Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
Condition: Angina
Interventions: Drug: Salvianolate injection;   Drug: Aspirin
6 Recruiting A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Condition: Advanced Solid Tumors
Intervention: Drug: TAS-102
7 Recruiting Alvocidib Biomarker-driven Phase 2 AML Study
Condition: Acute Myeloid Leukemia
Interventions: Drug: Alvocidib;   Drug: Cytarabine;   Drug: Mitoxantrone
8 Recruiting Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Conditions: Colon Cancer;   Rectal Cancer;   Liver Metastases
Interventions: Drug: Tas-102;   Device: SIR-Sphere
9 Recruiting Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
Conditions: Stroke;   Ischemic Attack, Transient
Interventions: Drug: Ticagrelor and Acetylsalicylic acid;   Drug: Clopidogrel and Acetylsalicylic acid

Study has passed its completion date and status has not been verified in more than two years.